The latest outbreak of Ebola virus disease
has caused the death of more than 9,400 people worldwide and created an international crisis that has shown few signs of stopping, continuing to infect thousands in West Africa.
Capobianchi, Antonino Di Caro; and the Lazzaro Spallanzani Institute for Research and Health Care Ebola Virus Disease
Sierra Leone Study Group2
Particularly in patients for whom Ebola virus disease
is only one item on a complicated differential diagnosis, the exclusive use of POC testing may compromise quality of care.
The experimental Ebola virus disease
vaccine VSV-EBOV has been proven to be effective in tests conducted on other primates.
"While there is an urgent need for product to be used on a compassionate basis, the ultimate goal should be product approval so that countries affected by Ebola Virus Disease
have products which have been demonstrated safe and effective at their disposal," WHO said.
"As on date, there is no confirmed or even suspect case of Ebola Virus Disease
"In view of the reports of outbreak of the Ebola Virus Disease
in 4 countries of West Africa, namely, Guinea, Liberia, Sierra Leone and Nigeria, it is recommended that non-essential travel to these countries be deferred till such time that the Ebola Virus Disease
outbreak situation is brought under control," he said.
Up to now, there is no approval treatment for Ebola virus disease
. Existing EBOV vaccines include DNA vaccine, recombinant subunit vaccine, virus-like particle vaccine and virus vector vaccine.
In March 2015 in Liberia, unprotected sexual intercourse was strongly suspected in the transmission of Ebola virus disease
(EVD) from a male survivor of EVD to his female partner (1).
The World Health Organization describes Ebola virus disease
(formerly known as Ebola hemorrhagic fever) as "a severe, often fatal illness, with a case fatality rate of up to 90%".
CDC is assisting ministries of health and working with other organizations to end the ongoing epidemic of Ebola virus disease
(Ebola) in West Africa (1).